We are live on ! Find out more
UBS

UBS Portfolio holdings

AUM $136B Turnover 18.95%
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$3.56B
Cap. Flow %
2.62%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,910
Closed
1,116
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1 year

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.72%
2 Energy 9.22%
3 Financials 6.8%
4 Healthcare 6.74%
5 Technology 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OI icon
6751
PUT
O-I Glass
OI
$788M
$52K ﹤0.01%
2,000
+1,600
+400% +$50.2K
2013 Q2
5 quarters
OSUR icon
6752
OraSure Technologies
OSUR
$272M
$52K ﹤0.01%
7,268
-4,616
-39% -$36.9K
2013 Q2
5 quarters
THO icon
6753
PUT
Thor Industries
THO
$3.81B
$52K ﹤0.01%
1,000
-3,200
-76% -$171K
2013 Q3
4 quarters
UCO icon
6754
CALL
ProShares Ultra Bloomberg Crude Oil
UCO
$493M
$52K ﹤0.01%
27
-2
-7% -$4.2K
2013 Q2
5 quarters
VECO icon
6755
CALL
Veeco
VECO
$2.38B
$52K ﹤0.01%
1,500
-182,600
-99% -$6.42M
2013 Q2
5 quarters
PCMI
6756
DELISTED
PCM, Inc
PCMI
$52K ﹤0.01%
5,331
-1,136
-18% -$11.6K
2013 Q2
5 quarters
KERX
6757
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$52K ﹤0.01%
3,800
– –
2013 Q2
5 quarters
DYN icon
6758
CALL
DELISTED
Dynegy, Inc.
DYN
$52K ﹤0.01%
+1,800
New +$53.5K
2014 Q3
0 quarters
UMX
6759
DELISTED
ProShares Ultra MSCI Mexico Capped IMI
UMX
$52K ﹤0.01%
1,143
-286
-20% -$13.6K
2014 Q1
2 quarters
NSR
6760
CALL
DELISTED
Neustar Inc
NSR
$52K ﹤0.01%
2,100
-1,800
-46% -$49.6K
2013 Q2
5 quarters
KATE
6761
CALL
DELISTED
Kate Spade & Company
KATE
$52K ﹤0.01%
2,000
-500
-20% -$17.1K
2013 Q2
5 quarters
BYLK
6762
DELISTED
BAYLAKE CORP
BYLK
$52K ﹤0.01%
4,385
+3,272
+294% +$40.3K
2013 Q4
3 quarters
FVI
6763
DELISTED
FIRST TR VALUE LINE EQUITY ALLOCATION INDEX FD
FVI
$52K ﹤0.01%
1,981
+1,601
+421% +$43K
2014 Q1
2 quarters
ACTG icon
6764
PUT
Acacia Research
ACTG
$423M
$51K ﹤0.01%
3,300
– –
2014 Q1
2 quarters
AG icon
6765
PUT
First Majestic Silver
AG
$7.03B
$51K ﹤0.01%
6,600
-14,300
-68% -$141K
2013 Q2
5 quarters
CBRE icon
6766
CALL
CBRE Group
CBRE
$37.1B
$51K ﹤0.01%
1,700
-1,100
-39% -$34.6K
2013 Q2
5 quarters
CFFI icon
6767
C&F Financial
CFFI
$357M
$51K ﹤0.01%
1,530
+1,430
+1,430% +$49.2K
2014 Q2
1 quarter
CIGI icon
6768
Colliers International
CIGI
$4.94B
$51K ﹤0.01%
1,647
+854
+108% +$26.7K
2013 Q2
5 quarters
CNVS icon
6769
Cineverse
CNVS
$38.9M
$51K ﹤0.01%
166
+156
+1,560% +$65.4K
2013 Q2
5 quarters
DXD icon
6770
PUT
ProShares UltraShort Dow 30
DXD
$43.5M
$51K ﹤0.01%
105
– –
2014 Q1
2 quarters
EWBC icon
6771
East-West Bancorp
EWBC
$17.9B
$51K ﹤0.01%
1,486
-4,539
-75% -$157K
2013 Q2
5 quarters
TBPH icon
6772
DELISTED
Theravance Biopharma
TBPH
$51K ﹤0.01%
2,177
-7,471
-77% -$217K
2014 Q2
1 quarter
TOWN icon
6773
Towne Bank
TOWN
$3.43B
$51K ﹤0.01%
3,773
-626
-14% -$9.27K
2013 Q2
5 quarters
WEAT icon
6774
CALL
Teucrium Wheat Fund
WEAT
$242M
$51K ﹤0.01%
+940
New +$58.7K
2014 Q3
0 quarters
CIR icon
6775
DELISTED
CIRCOR International, Inc
CIR
$51K ﹤0.01%
758
+26
+4% +$1.86K
2013 Q2
5 quarters

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,910 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.